Medindia

X

Rabies Vaccine Found to be Effective Even in Limited Refrigeration Facilities

by Madhumathi Palaniappan on  October 26, 2016 at 10:37 AM Drug News   - G J E 4
A research team from the Washington State University found that storing rabies vaccines at a warm temperature between 25 -30℃ will still protect dogs from various diseases.
Rabies Vaccine Found to be Effective Even in Limited Refrigeration Facilities
Rabies Vaccine Found to be Effective Even in Limited Refrigeration Facilities
Advertisement

The study published in the journal Vaccine would help to improve vaccine coverage in rural areas where there is limited cooling electricity especially in places like Africa and Asia.

‘Limited Refrigeration facilities for Rabies vaccine can improve coverage even in rural areas of Africa and Asia.’
Advertisement
Felix Lankester, author and clinical assistant, WSU Paul G. Allen School for Global Animal Health, said "Thermotolerant vaccines were a really important feature of the campaign to eliminate smallpox."

"We hope it will have the same effect for eradicating rabies."he added.

Recommendations by the World Health Organization are for vaccines to be transported and stored in a "cold chain" at between 2C (35.6F) and 8C (46.4F). Lankester and his colleagues found that Nobivac, a commonly used rabies vaccine, produces the same level of protective antibodies in dogs after being stored for six months at 25C (77F) and for three months at 30C (86F). "The ability to distribute vaccines widely outside the cold chain will allow for more consistent coverage across communities," said Lankester. "It could be a quantum shift in how vaccines are delivered."

Eradicating one of the deadliest diseases

"Human rabies from dog bites has the highest fatality rate of any human infectious disease," said Guy Palmer, WSU's senior director of global health. "But rabies is easily preventable with regular dog vaccinations.

felix-administering-vaccine-2015-web

Felix Lankester, left, WSU clinical assistant professor, takes a blood sample to test whether a rabies vaccine stored at warmer temperatures is effective against the disease.

Each year roughly 60,000 people, mostly children, die from rabies. Globally, more than 99 percent of human rabies deaths are caused by dog bites -- almost all in sub-Saharan Africa and Asia. Millions of people are saved by costly post-exposure prophylaxis - a series of post-bite vaccinations, the first of which must be administered within the first 24 hours after a person is bitten by a rabid dog. But once symptoms appear, the disease is fatal.

Vaccinating 70 percent of the dog population will protect humans and wildlife, such as endangered African wild dogs, from the disease.

WSU, in collaboration with the Serengeti Health Initiative, has been working to control rabies in areas of northern Tanzania through annual mass dog rabies vaccination campaigns. But rabies continues to be prevalent, in part because of the challenges of transporting vaccines to remote areas where vulnerable people live in resource-poor communities.

"If a team-led vaccination campaign misses a village because it is very far or because rain washed out a bridge, then there will be pockets where vaccination coverage is low," said Lankester. "With a community-led initiative, we are hopeful we would improve the coverage levels."

Empowering communities to lead vaccination programs

Mass vaccination teams generally only visit communities once a year, if they can get there at all. When new dogs are born or move into the community, the level of protection against rabies drops. In community-led programs, thermotolerant vaccines could be stored in the community where local coordinators would vaccinate the entire dog population.

"Through community-led programs, coverage could be kept relativity consistently high, which would reduce the likelihood of rabies returning to a community," said Lankester. "These findings also give confidence to those working to control rabies that if vaccines are kept outside of the cold chain for a small time, they don't have to be thrown away."

In the next phase of the research, Lankester and his colleagues will test the effectiveness of using low-tech cooling options for storing rabies vaccines in rural communities.



Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All